drugset / Trial / NCT02068157
Interstitial Photodynamic Therapy in Treating Patients With Recurrent Head and Neck Cancer
Phase 2
Terminated
3 enrolled
Roswell Park Cancer Institute
National Cancer Institute (NCI) · collab
NaSingle-groupOpen-labelTreatment
Summary
This phase II trial studies the effects of interstitial photodynamic therapy in patients with head and neck cancer that has come back. Interstitial photodynamic therapy uses a combination of laser light and a light-sensitive drug called porfimer sodium to destroy tumors. During treatment a laser light is used to activate the drug. Interstitial photodynamic therapy may be an effective treatment for head and neck cancer.
Timeline
- Start
- 2014-04-01
- Primary completion
- 2016-10-13
- Completion
- 2016-11-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | porfimer sodium | Small molecule | — | Intravenous |